Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Artemisinins are plant products with a wide range of medicinal applications. Most prominently, artesunate is a well tolerated and effective drug for treating malaria, but is also active against several protozoal and schistosomal infections, and additionally exhibits anti-angiogenic, anti-tumorigenic and anti-viral properties. The array of activities of the artemisinins, and the recent emergence of malaria resistance to artesunate, prompted us to synthesize and evaluate several novel artemisinin-like derivatives. Sixteen distinct derivatives were therefore synthesized and the in vitro cytotoxic effects of each were tested with different cell lines. The in vivo anti-angiogenic properties were evaluated using a zebrafish embryo model. We herein report the identification of several novel artemisinin-like compounds that are easily synthesized, stable at room temperature, may overcome drug-resistance pathways and are more active in vitro and in vivo than the commonly used artesunate. These promising findings raise the hopes of identifying safer and more effective strategies to treat a range of infections and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954 · cited 1×
“In spite of its therapeutic utility in treating malaria, resistant strains of the malaria parasites are emerging, mostly in western Cambodia, where treatment failure rates after combination therapy have exceeded 10% [24].”
BackgroundThe Antiviral Activities of Artemisinin and Artesunate
Efferth, T., Romero, M. R., Wolf, D. G., Stamminger, T., Marin, J. J. G., & Marschall, M. (2008) · Clinical Infectious Diseases · doi:10.1086/591195 · Cited by 503
Self-citationNakase, I., Lai, H., Singh, N. P., & Sasaki, T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.003 · Cited by 190
Haynes, R. K., Chan, W. C., Lung, C., Uhlemann, A., Eckstein, U., Taramelli, D., Parapini, S., Monti, D., & Krishna, S. (2007) · ChemMedChem · doi:10.1002/cmdc.200700108 · Cited by 123
Cited by
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Efferth, T. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.009 · Cited by 632
Self-citationCrespo-Ortiz, M. P., & Wei, M. Q. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/247597 · Cited by 382
Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
Dolivo, D., Weathers, P., & Dominko, T. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.001 · Cited by 132
Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives
Xu, C.-C., Deng, T., Fan, M.-L., Lv, W.-B., Liu, J.-H., & Yu, B.-Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.11.003 · Cited by 75
Metadata
- Authors
- Soomro, S., Langenberg, T., Mahringer, A., Konkimalla, V. B., Horwedel, C., Holenya, P., Brand, A., Cetin, C., Fricker, G., Dewerchin, M., Carmeliet, P., Conway, E. M., Jansen, H., & Efferth, T.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2010-07-12
- Volume
- 15
- Issue
- 5
- Pages
- 1122-1135
- ISSN
- 1582-1838 (ISSN-L)
- OpenAlex
- W1968570263
- Cited by
- 54
- References
- 4
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties. https://app.cochat.ai/papers/10.1111/j.1582-4934.2010.01120.x
- The paper
- Soomro, S., Langenberg, T., Mahringer, A., Konkimalla, V. B., Horwedel, C., Holenya, P., Brand, A., Cetin, C., Fricker, G., Dewerchin, M., Carmeliet, P., Conway, E. M., Jansen, H., & Efferth, T. (2011). Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2010.01120.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.